Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Warner-Lambert discloses new IL-8 (CXCR1/CXCR2) receptor antagonists

Sep. 16, 1999

Abgenix reports positive preclinical results for ABX-IL-8

Sep. 15, 1999

Hair growth promoters developed at Shiseido

Sep. 13, 1999

Access initiates clinical trial of OraDisc for amlexanox delivery

Sep. 10, 1999

Fujisawa seeks approval for tacrolimus ointment in the U.S.

Sep. 10, 1999

Vitrix soon to enter expanded clinical development

Sep. 10, 1999

Licensing opportunity from NIH: thymosin beta4 as a wound-healing agent

Sep. 7, 1999

Genzyme Tissue Repair's TGF-beta2 sponge evaluated in phase II diabetic foot ulcers

Sep. 3, 1999

ACS news: new compounds from Merck & Co. potently and selectively inhibit 5alpha-reductase type 1

Sep. 1, 1999

AGN-194310, a high-affinity RAR antagonist for treating retinoid-induced toxicities

Sep. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026